338 related articles for article (PubMed ID: 37744371)
1. Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities.
Wang B; Pei J; Xu S; Liu J; Yu J
Front Immunol; 2023; 14():1246682. PubMed ID: 37744371
[TBL] [Abstract][Full Text] [Related]
2. The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.
Amanpour S
Arch Razi Inst; 2021 Mar; 76(1):1-6. PubMed ID: 33818952
[TBL] [Abstract][Full Text] [Related]
3. mRNA Vaccines: The Dawn of a New Era of Cancer Immunotherapy.
Deng Z; Tian Y; Song J; An G; Yang P
Front Immunol; 2022; 13():887125. PubMed ID: 35720301
[TBL] [Abstract][Full Text] [Related]
4. Clinical advances and ongoing trials on mRNA vaccines for cancer treatment.
Lorentzen CL; Haanen JB; Met Ö; Svane IM
Lancet Oncol; 2022 Oct; 23(10):e450-e458. PubMed ID: 36174631
[TBL] [Abstract][Full Text] [Related]
5. mRNA vaccines for cancer immunotherapy.
Vishweshwaraiah YL; Dokholyan NV
Front Immunol; 2022; 13():1029069. PubMed ID: 36591226
[TBL] [Abstract][Full Text] [Related]
6. The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines.
Wei J; Hui AM
Cancer Treat Rev; 2022 Jun; 107():102405. PubMed ID: 35576777
[TBL] [Abstract][Full Text] [Related]
7. Recent progress in mRNA cancer vaccines.
Yao R; Xie C; Xia X
Hum Vaccin Immunother; 2024 Dec; 20(1):2307187. PubMed ID: 38282471
[TBL] [Abstract][Full Text] [Related]
8. Personalized pancreatic cancer therapy: from the perspective of mRNA vaccine.
Huang X; Zhang G; Tang TY; Gao X; Liang TB
Mil Med Res; 2022 Oct; 9(1):53. PubMed ID: 36224645
[TBL] [Abstract][Full Text] [Related]
9. mRNA vaccine in cancer therapy: Current advance and future outlook.
Li Y; Wang M; Peng X; Yang Y; Chen Q; Liu J; She Q; Tan J; Lou C; Liao Z; Li X
Clin Transl Med; 2023 Aug; 13(8):e1384. PubMed ID: 37612832
[TBL] [Abstract][Full Text] [Related]
10. Path towards mRNA delivery for cancer immunotherapy from bench to bedside.
Chen W; Zhu Y; He J; Sun X
Theranostics; 2024; 14(1):96-115. PubMed ID: 38164145
[TBL] [Abstract][Full Text] [Related]
11. Clinical Development of mRNA Vaccines: Challenges and Opportunities.
August A; Brito L; Paris R; Zaks T
Curr Top Microbiol Immunol; 2022; 440():167-186. PubMed ID: 35906319
[TBL] [Abstract][Full Text] [Related]
12. Perspectives and Prospects on mRNA Vaccine Development for COVID-19.
Jin L; Han Z; Zhao P; Sun K
Curr Med Chem; 2022; 29(23):3991-3996. PubMed ID: 35170403
[TBL] [Abstract][Full Text] [Related]
13. mRNA Vaccine - A New Cancer Treatment Strategy.
Tan T; Deng ST; Wu BH; Yang Q; Wu MW; Wu H; Cao CH; Xu C
Curr Cancer Drug Targets; 2023; 23(9):669-681. PubMed ID: 36809966
[TBL] [Abstract][Full Text] [Related]
14. Challenges and advances towards the rational design of mRNA vaccines.
Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
[TBL] [Abstract][Full Text] [Related]
15. Potentialities and Challenges of mRNA Vaccine in Cancer Immunotherapy.
Duan LJ; Wang Q; Zhang C; Yang DX; Zhang XY
Front Immunol; 2022; 13():923647. PubMed ID: 35711457
[TBL] [Abstract][Full Text] [Related]
16. Messenger RNA vaccines for cancer immunotherapy: progress promotes promise.
Huff AL; Jaffee EM; Zaidi N
J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35289317
[TBL] [Abstract][Full Text] [Related]
17. mRNA Cancer Vaccines: Construction and Boosting Strategies.
Liu X; Huang P; Yang R; Deng H
ACS Nano; 2023 Oct; 17(20):19550-19580. PubMed ID: 37819640
[TBL] [Abstract][Full Text] [Related]
18. Adjuvants for cancer mRNA vaccines in the era of nanotechnology: strategies, applications, and future directions.
Cao LM; Yu YF; Li ZZ; Zhong NN; Wang GR; Xiao Y; Liu B; Wu QJ; Feng C; Bu LL
J Nanobiotechnology; 2024 Jun; 22(1):308. PubMed ID: 38825711
[TBL] [Abstract][Full Text] [Related]
19. Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines.
Guevara ML; Persano S; Persano F
Curr Pharm Des; 2019; 25(13):1443-1454. PubMed ID: 31258071
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 mRNA vaccines: Platforms and current developments.
Szabó GT; Mahiny AJ; Vlatkovic I
Mol Ther; 2022 May; 30(5):1850-1868. PubMed ID: 35189345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
